Presentation is loading. Please wait.

Presentation is loading. Please wait.

Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving Radiation Therapy With or Without Chemotherapy  Barbara.

Similar presentations


Presentation on theme: "Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving Radiation Therapy With or Without Chemotherapy  Barbara."— Presentation transcript:

1 Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving Radiation Therapy With or Without Chemotherapy  Barbara A. Murphy, MD, Jennifer L. Beaumont, MS, John Isitt, MS, Adam S. Garden, MD, Clement K. Gwede, PhD, MPH, Andy M. Trotti, MD, Ruby F. Meredith, MD, Joel B. Epstein, DMD, MSD, Quynh-Thu Le, MD, David M. Brizel, MD, Lisa A. Bellm, MIM, Nancy Wells, DNSc, David Cella, PhD  Journal of Pain and Symptom Management  Volume 38, Issue 4, Pages (October 2009) DOI: /j.jpainsymman Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions

2 Fig. 1 Maximum severity of mouth and throat soreness by type of radiation therapy. The rates of severe pain were not significantly different (P=0.175 by Fisher's exact test) with regard to radiation technique. Conventional RT=conventional RT±CB. Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman ) Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions

3 Fig. 2 Opioid use. a) Route of administration. b) Severity of mouth and throat soreness over time, according to opioid use. The overall test for the effect of time was statistically significant (P<0.001 by general linear model). Changes in mouth and throat soreness at each time point compared with baseline were also statistically significant (P<0.001 by general linear model). c) Mean OMWQ-HN scores over time, according to opioid use. Scores among patients taking opioids were significantly greater than those among patients not taking opioids at Weeks 1–2 (P=0.025) and 3–4 (P=0.001), and were not significantly different at Weeks 5–6 (P=0.256). Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman ) Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions

4 Fig. 3 Hospitalizations and their relationship with mucositis.
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman ) Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions


Download ppt "Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving Radiation Therapy With or Without Chemotherapy  Barbara."

Similar presentations


Ads by Google